Analytic Investors’s Celgene Corp CELG Stock Holding History

Analytic Investors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.09M	Sell	10,434 -69,009	-87%	-$7.47M	0.01%	356
2016 Q2	$7.84M	Buy	+79,443	New	+$8.22M	0.09%	164
2015 Q3	–	Sell	-21,255	Closed	-$2.46M	–	687
2015 Q2	$2.46M	Buy	+21,255	New	+$2.43M	0.03%	255
2014 Q3	–	Sell	-19,164	Closed	-$1.65M	–	724
2014 Q2	$1.65M	Sell	19,164 -38,332	-67%	-$2.92M	0.03%	262
2014 Q1	$4.01M	Sell	57,496 -213,856	-79%	-$16.9M	0.06%	208
2013 Q4	$22.9M	Buy	271,352 +190,084	+234%	+$15M	0.38%	79
2013 Q3	$6.26M	Buy	+81,268	New	+$5.7M	0.1%	173

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Analytic Investors's CELG Position: Q3 2016 in Review

Analytic Investors reduced its Celgene Corp (CELG) stake by 87% in Q3 2016, selling an estimated $7.47M and leaving 10,434 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #356.

Analytic Investors first reported a position in CELG in Q3 2013 and has held it in 7 quarters since. The position peaked at $22.9M in Q4 2013. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

Analytic Investors held 10,434 shares of Celgene Corp worth $1.09M as of Q3 2016.
Analytic Investors sold 69,009 Celgene Corp shares in Q3 2016, an estimated $7.47M.
Celgene Corp made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #356 holding.
Analytic Investors first reported a position in Celgene Corp in Q3 2013 and has held it in 7 quarters since.
Analytic Investors's Celgene Corp position peaked at $22.9M in Q4 2013.
1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.